Follow-The-Filings

Holders · period archive

BBIO · Bridgebio Pharma Inc.

Q4 2023 13F holders among managers we track latest ownership dossier

Ticker
BBIO
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares